The global contraceptive market is projected to grow from USD 19.79 billion in 2024 to USD 33.79 billion by 2034, registering a compound annual growth rate (CAGR) of 5.5% during the forecast period. This robust growth reflects increasing awareness of modern contraception and its vital role in family planning and reproductive health.
Key drivers of market expansion include rising education levels, greater access to healthcare, and heightened awareness of the benefits of contraception. Modern methods, ranging from hormonal drugs to advanced intrauterine devices (IUDs), are gaining traction as they provide safe and effective pregnancy prevention options.
Governments and health organizations globally are also intensifying efforts to promote contraceptive use, especially in underserved regions. These initiatives aim to address issues such as unplanned pregnancies and associated health risks, further fueling market demand.
A Full Report Overview – https://www.futuremarketinsights.com/reports/contraceptives-market
Key Takeaways:
- The contraceptive market is forecast to grow at a 5.5% CAGR, reaching USD 33.79 billion by 2034 from USD 19.79 billion in 2024.
- Factors such as family planning, higher education, and health awareness drive market growth.
- Modern contraceptive methods, including hormonal drugs and IUDs, are increasingly preferred for their safety and efficacy.
- Government and health organization initiatives play a key role in expanding access and adoption globally.
Market Drivers
- Family Planning Initiatives: Growing awareness and initiatives surrounding family planning are driving the adoption of contraceptive methods across various demographics.
- Higher Education Levels: Increased educational attainment, particularly among women, correlates with a greater understanding and acceptance of contraceptive options.
- Health Concerns: Rising health issues related to unplanned pregnancies and sexually transmitted diseases (STDs) are prompting more individuals to seek contraceptive solutions.
- Awareness of Modern Contraception: There is an increasing awareness of modern contraceptive methods, which is contributing to the growth of the market as more individuals seek effective birth control options.
- Government Support and Programs: Many governments are implementing programs aimed at reducing unwanted pregnancies, which includes promoting access to contraceptives.
Regional Insights
- The North American region is expected to dominate the market due to high awareness levels and access to a wide range of contraceptive products.
- Europe and Asia-Pacific are also projected to see significant growth driven by increasing health awareness and improved healthcare access.
Consumption Analysis of the Contraceptive Market
- The industry’s growth is predicted to be accelerated by implementing programs to reduce unwanted pregnancies and healthcare costs and increasing user awareness.
- The World Health Organization (W.H.O.) collaborates with medical partners to enhance family planning and reproductive health outcomes, improve accessibility of contraception tools, streamline programs, and mobilize global commitments.
- The development of the contraception market is driven by the need to reduce unplanned pregnancies, especially among teenage women, which is a major factor in the demand for contraception.
- The increasing population, particularly in low and middle-income countries, has led to heightened awareness about contraception methods, with the introduction of over-the-counter products fueling market development.
- The market’s evolution is guided by the prevalence of unwanted pregnancies, sexually transmitted diseases, technological advancements, and awareness about sexual health, with favorable government policies influencing market growth.
- The demand for contraceptives is envisioned to expand due to increased awareness, population control efforts, and rising demand, with retail pharmacies dominating the industry due to improved supply chain networks.
- Governments are focusing more on providing timely and affordable services and increasing access to modern contraception, yet almost 214 million women globally still lack access to it. State representatives emphasize the significance of timely and affordable contraception care.
Market Players Shaping the Outlook of the Contraceptive Market
The market is a competitive and rapidly evolving industry. Key players focus on diverse techniques to stay ahead of the competition and augment their presence in the market. Effective strategies are to acquire or collaborate with companies to improve their product portfolio and market penetration.
Companies, in addition to acquisitions and collaborations, prioritize gaining FDA approvals to ensure the safety and effectiveness of their products, giving them a competitive edge over competitors who may not have received the necessary approvals.
The leading companies are well known for their innovative products and commitment to providing safe and effective contraception to women globally. By leveraging these key strategies, they are able to stay ahead of the competition and continue to grow their businesses in a rapidly evolving market.
Recent Developments in the Contraceptive Market
- In December 2023, United Kingdom’s researchers started trials for a non-hormonal male birth control pill, YCT-529, developed by Quotient Sciences. The trial involves 16 British men, aiming to shift the burden of preventing unwanted pregnancies from women to men. YCT-529 blocks access to vitamin A, preventing infertility.
- In December 2023, Aditxt acquired Evofem Biosciences, creator of the first hormone-free contraceptive gel, Phexxi, under a definitive agreement focusing on health innovations and women’s health.
- In October 2023, the Indian Council of Medical Research (ICMR) completed clinical trials for the world’s first injectable male contraceptive, demonstrating its safety and efficacy without serious side effects.
- In July 2023, The FDA approved Perrigo’s Opill, the first nonprescription birth control pill in the United States, making it more effective than other nonprescription methods, potentially expanding access to contraception.
- In June 2023, the Biden-Harris Administration announced a public-private partnership with Upstream to improve access to contraception and address growing health disparities in the United States.
- In March 2023, NEXT Life Sciences plans to launch Plan A™, a safe, effective, and reversible male contraceptive product. The company will participate in LSI’s 2023 Emerging Medtech Summit in Dana Point, California, to showcase its product and engage with investors.
Key Companies
- Bayer AG Pfizer Inc.
- Janssen Global Services, LLC
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Allergan Plc.
- Reckitt Benckiser Group plc.
- Veru Inc.
- Church & Dwight Co., Inc.
- Medisafe Distribution Inc.
- Cooper Surgical, Inc.
- Mayer Laboratories, Inc.
- Pfizer Inc.
- The Female Health Company
- Exeltis USA, Inc.
Key Segments
By Product:
- Drugs
- Oral Contraceptive Pills
- Injectable Contraceptive
- Topical Contraceptive
- Devices
- Condoms
- Diaphragms
- Contraceptive Sponges
- Vaginal Rings
- Cervical Cap
- Subdermal Implants
- Intra-uterine Devices
- Copper
- Hormonal
By Gender:
- Female
- Male
By End User:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Retail Sales
- Retail Pharmacy
- Drug Stores
- Supermarkets or Hypermarkets
- Online Sales
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube